Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial - Concepedia

Concepedia

Publication | Open Access

Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial

DOI Full Paper Access

32

Citations

21

References

2019

Year

Geert Leroux‐Roels, Zourab Bebia, Cathy Maes, Annelies Aerssens, Fien De Boever, Luca Grassano, Giada Buffi, Immaculada Margarit, Annette Karsten, Stephen Cho,

Clinical Infectious Diseases

Abstract

NCT02690181.

References

	Year	Citations

Page 1